Axel Gaston Glasmacher
Président chez 4D PHARMA PLC
Postes actifs de Axel Gaston Glasmacher
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| 4D PHARMA PLC | Independent Dir/Board Member | 08/01/2019 | - |
| Président | 17/04/2020 | - | |
| Directeur/Membre du Conseil | 08/01/2019 | 17/04/2020 | |
| RYVU THERAPEUTICS S.A. | Directeur/Membre du Conseil | 01/10/2019 | - |
| ACTIVE BIOTECH AB | Directeur/Membre du Conseil | 01/01/2020 | - |
| Independent Dir/Board Member | 01/01/2020 | - | |
| The Cancer Drug Development Forum | Directeur/Membre du Conseil | - | - |
| Treasurer | - | - | |
| AG Life Science Consulting Gmbh & Co. Kg | Directeur Général | - | - |
| Directeur/Membre du Conseil | 01/03/2018 | - | |
| Glasmacher Verwaltungs GmbH | Directeur Général | - | - |
| Directeur/Membre du Conseil | - | - | |
AvenCell Therapeutics, Inc.
 AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | Directeur/Membre du Conseil | 01/07/2021 | - |
Historique de carrière de Axel Gaston Glasmacher
Anciens postes connus de Axel Gaston Glasmacher
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CELGENE | Directeur Technique/Scientifique/R&D | 01/05/2006 | 01/02/2018 |
Formation de Axel Gaston Glasmacher
| University of Bonn | Doctorate Degree |
Statistiques
Internationale
| Allemagne | 4 |
| Etats-Unis | 3 |
| Royaume-Uni | 2 |
Opérationnelle
| Director/Board Member | 7 |
| Independent Dir/Board Member | 2 |
| Chief Executive Officer | 2 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| 4D PHARMA PLC | Health Technology |
| RYVU THERAPEUTICS S.A. | Health Technology |
| ACTIVE BIOTECH AB | Health Technology |
| Entreprise privées | 5 |
|---|---|
| The Cancer Drug Development Forum | |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
| AG Life Science Consulting Gmbh & Co. Kg | |
| Glasmacher Verwaltungs GmbH | |
AvenCell Therapeutics, Inc.
AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | Health Technology |
- Bourse
- Insiders
- Axel Gaston Glasmacher
- Expérience
